Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Plain-language summaries of 10,888 rare conditions, drawn from MONDO, GeneReviews, ClinVar, FDA, NIH, ClinicalTrials.gov, PubMed, and 5 other public sources. Free, sourced, never gated.
Kisho provides public health information only — not medical advice. Always consult your healthcare provider.
12
authoritative sources — clinical, regulatory, scientific
10,888
rare conditions, continuously monitored
Daily
updates from MONDO, HPO, ClinicalTrials.gov, FDA, Orphanet…
Showing 10,821-10,840 of 10,888 diseases
MONDO:0016193
Neuromuscular disease caused by qualitative or quantitative defects of alpha-actin is a condition that affects muscle function and overall mobility. T...
MONDO:0018282
Neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan is a condition that primarily impacts the muscles and may af...
MONDO:0016195
This neuromuscular condition is associated with defects in the beta-myosin heavy chain, a protein crucial for muscle contraction. It is linked to alte...
MONDO:0016145
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, also known as dysferlinopathy, is a condition that affects muscle fu...
MONDO:0016147
Neuromuscular disease caused by qualitative or quantitative defects of dystrophin is a condition that primarily affects muscle function and structure....
MONDO:0016186
Neuromuscular disease caused by qualitative or quantitative defects of myofibrillar proteins is a condition that primarily affects muscle function. Al...
MONDO:0016194
Neuromuscular disease caused by qualitative or quantitative defects of nebulin is a condition that impacts the muscles responsible for movement. Altho...
MONDO:0016151
This neuromuscular disorder is characterized by defects in the production or structure of perlecan, a key protein encoded by the HSPG2 gene. It primar...
MONDO:0016198
Neuromuscular disease caused by qualitative or quantitative defects of plectin is a condition that primarily affects the skeletal muscles, leading to...
MONDO:0016199
MONDO:0016197
This neuromuscular condition is characterized by impaired muscle strength and function, although detailed clinical findings have not yet been fully de...
MONDO:0016192
Neuromuscular disease caused by qualitative or quantitative defects of telethonin is a condition that affects muscle function. It arises from issues i...
MONDO:0016191
Neuromuscular disease caused by qualitative or quantitative defects of titin is a condition that primarily affects muscle strength and function. Altho...
MONDO:0016153
Neuromuscular disease caused by qualitative or quantitative defects of TRIM32 is a condition that affects the muscles and can impact physical strength...
MONDO:0017303
Neuromuscular disease caused by qualitative or quantitative defects of tropomyosin is a condition that primarily affects muscle function. Although the...
MONDO:0958332
MONDO:0020124
Neuromuscular junction disease refers to a group of conditions characterized by impaired transmission of nerve impulses to muscles, often resulting in...
MONDO:0019100
Neuromyelitis optica is a rare inflammatory disease of the central nervous system that primarily presents with episodes of optic neuritis and acute my...
MONDO:0035663
Neuromyelitis optica spectrum disorder (NMOSD) with anti-AQP4 antibodies is characterized by the presence of antibodies against aquaporin-4, a water c...
MONDO:0035664
Neuromyelitis optica spectrum disorder with anti-MOG antibodies (NMOSD with anti-MOG) is a rare autoimmune condition characterized by the presence of...
Built from MONDO, HPO, ClinicalTrials.gov, FDA, Orphanet, and 7 more public sources. Updated daily.